Clinical Trial Update: IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating low-dose naltrexone for interstitial cystitis/painful bladder syndrome was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Pain Syndrome
• Interstitial Cystitis
• Painful Bladder Syndrome

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Endeavor Health | Conditions: Interstitial Cystitis, Painful Bladder Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2025-03-07